Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adriamycin-induced myocardial lesions. Report of a workshop.

× No keyword cloud information.

7 in total

1. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.

Authors: N Iliskovic; P K Singal
Journal: Am J Pathol Date: 1997-02 Impact factor: 4.307

2. Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.

Authors: Xiuli Wei; Yiguang Wang; Wenfeng Zeng; Feng Huang; Lei Qin; Chunling Zhang; Wei Liang
Journal: Pharm Res Date: 2012-03-17 Impact factor: 4.200

3. The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat.

Authors: T K Yeung; R S Jaenke; D Wilding; A M Creighton; J W Hopewell
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 4. Adriamycin-induced heart failure: mechanism and modulation.

Authors: P K Singal; T Li; D Kumar; I Danelisen; N Iliskovic
Journal: Mol Cell Biochem Date: 2000-04 Impact factor: 3.396

5. Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.

Authors: W Fitter; D J deSa; K R Pai
Journal: J Clin Pathol Date: 1981-06 Impact factor: 3.411

6. Low R-wave amplitude in the right precordial leads in children with symptomatic doxorubicin cardiomyopathy.

Authors: M Umemoto; E Azuma; M Itoh; Y Komada; M Ido; H Kawasaki; H Kita; M Sakurai
Journal: Pediatr Cardiol Date: 1993-03 Impact factor: 1.655

7. Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study.

Authors: C B Pratt; T J Vietti; E Etcubanas; C Sexauer; R A Krance; D H Mahoney; R B Patterson
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

7 in total